Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AZ, IMS To Build Disparate Data Sets Into Broader Outcomes Consensus

Executive Summary

Individual deals with payers or information providers won’t provide pharma with the breadth of outcomes data they need to secure reimbursement for their drugs. A far broader stakeholder consensus is required.

You may also be interested in...



Swedish Real World COPD Pneumonia Analysis Backs Symbicort Over Seretide

COPD stalwarts Symbicort and Seretide never have been compared head-to-head in the clinic but Swedish researchers now have analyzed the pair’s respective association with pneumonia, using Sweden’s modern infrastructure and national databases. The review concluded that the AstraZeneca compound soundly beats GlaxoSmithKline’s, based on real-world evidence.

Payers’ Use Of Real-World Evidence For Drug Coverage On The Rise – IMS Health

A new study by IMS Health shows payers globally are making more drug reimbursement decisions based on real-world evidence – including 25% of more than 100 identified case studies using biopharma industry-generated data.

Creating Value In Pharma-Health Plan Collaborations

A wave of research-based collaborations between pharmaceutical companies and payors is enabling a new level of credibility, trust, and joint efforts to enhance patient care.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054137

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel